Domain-Specific vs. General-Purpose Large Language Models in Orthodontics: A Blinded Comparison of AlimGPT, GPT-4o, Gemini, and Llama

正畸学中的特定领域与通用大型语言模型:AlimGPT、GPT-4o、Gemini 和 Llama 的盲法比较

阅读:1

Abstract

Objective: The application of artificial intelligence (AI) in orthodontics has evolved rapidly in recent years, encompassing areas such as diagnosis, treatment planning, and patient management, and AlimGPT is an AI-based tool that provides treatment options based on data and algorithms. Methods: Fourteen different orthodontic questions were asked to each model, and answers were analyzed. This study aimed to compare AlimGPT with GPT-4o, Gemini, and Llama using standardized tests to evaluate the quality of information provided, including the Likert scale, modified DISCERN (mDISCERN), and modified Global Quality Score (mGQS). Results: Significant differences were detected for reliability (χ(2) = 15.267, p = 0.0016) and usefulness (χ(2) = 20.557, p = 0.0001). Post hoc tests showed AlimGPT > Gemini and Llama for reliability and AlimGPT > GPT-4o, Gemini, and Llama for usefulness. mDISCERN was significant overall (χ(2) = 11.047, p = 0.0115), but no pairwise contrast met adjusted significance; mGQS showed no significant differences (χ(2) = 7.071, p = 0.0697). Inter-rater agreement was moderate-to-good for reliability (ICC = 0.710, 95% CI 0.60-0.80) and usefulness (ICC = 0.729, 95% CI 0.63-0.82), moderate for mGQS (ICC = 0.596, 95% CI 0.47-0.71), and poor-to-moderate for mDISCERN (ICC = 0.435, 95% CI 0.30-0.58). Conclusions: In this blinded, within-subjects experiment, the domain-specific model (AlimGPT) received higher clinician ratings for usefulness and, for reliability, exceeded two general baselines. Differences in mGQS were not detected. Expanding the number of raters, increasing item diversity or integrating updated baselines would be beneficial.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。